BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24979756)

  • 1. Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.
    Kaldenbach M; Cubero FJ; Erschfeld S; Liedtke C; Trautwein C; Streetz K
    PLoS One; 2014; 9(6):e100786. PubMed ID: 24979756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
    Mohs A; Kuttkat N; Otto T; Youssef SA; De Bruin A; Trautwein C
    Carcinogenesis; 2020 Apr; 41(2):171-181. PubMed ID: 30770929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
    Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
    Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
    Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
    Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
    Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
    Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
    Kaldenbach M; Giebeler A; Tschaharganeh DF; Erschfeld S; Wasmuth HE; Dolle L; Floege J; Trautwein C; Streetz KL
    Gut; 2012 Aug; 61(8):1209-18. PubMed ID: 22287599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
    Streetz KL; Doyonnas R; Grimm D; Jenkins DD; Fuess S; Perryman S; Lin J; Trautwein C; Shizuru J; Blau H; Sylvester KG; Kay MA
    Hepatology; 2008 Feb; 47(2):706-18. PubMed ID: 18220289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
    Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
    J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.
    Mizutani N; Hikita H; Saito Y; Myojin Y; Sato K; Urabe M; Kurahashi T; Shiode Y; Sakane S; Murai K; Nozaki Y; Kodama T; Sakamori R; Yoshida Y; Tatsumi T; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G958-G968. PubMed ID: 33787344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice.
    Tschaharganeh DF; Kaldenbach M; Erschfeld S; Tischendorf JJ; Trautwein C; Streetz KL
    Liver Transpl; 2010 Jan; 16(1):23-32. PubMed ID: 20035522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
    Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
    Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
    Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
    Chen WT; Ha D; Kanel G; Lee AS
    Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.
    Lu XF; Zhou YJ; Zhang L; Ji HJ; Li L; Shi YJ; Bu H
    World J Gastroenterol; 2015 Jun; 21(21):6591-603. PubMed ID: 26074697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.